PPD (PPD) Cash, Cash Equivalents, Marketable Securities : $1,173 Mil (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is PPD Cash, Cash Equivalents, Marketable Securities?

PPD's quarterly cash, cash equivalents, marketable securities increased from Mar. 2021 ($826.43 Mil) to Jun. 2021 ($949.00 Mil) and increased from Jun. 2021 ($949.00 Mil) to Sep. 2021 ($1,172.72 Mil).

PPD's annual cash, cash equivalents, marketable securities declined from Dec. 2018 ($553.07 Mil) to Dec. 2019 ($345.19 Mil) but then increased from Dec. 2019 ($345.19 Mil) to Dec. 2020 ($768.00 Mil).

PPD Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for PPD's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Cash, Cash Equivalents, Marketable Securities Chart

PPD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Cash, Cash Equivalents, Marketable Securities

418.96

553.07

345.19

768.00

PPD Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial									803.09	768.00	826.43	949.00	1,172.72

PPD Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

PPD (NAS:PPD) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

PPD Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of PPD's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

PPD (PPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

929 North Front Street, Wilmington, NC, USA, 28401

Website

https://www.ppdi.com

PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.

Executives

H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons	director, officer: Chief Executive Officer	PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan	officer: Chief Accounting Officer	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow	officer: See Remarks	2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman	officer: See Remarks	3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino	officer: SVP & General Manager of AES	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p.	10 percent owner	ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick	director	C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004